Vanderbilt Heart and Vascular Institute Archives

Hall of Fame company

Feb. 7, 2020—Hall of Fame wide receiver Raymond Berry wore a tie honoring VUMC when he was named to the NFL’s 100th Anniversary All-Time Team and was recognized at the Super Bowl in Miami on Feb. 2.

Interim directors of Cardiovascular Medicine named

Jan. 9, 2020—Dan Roden, MD, and Daniel Munoz, have been named interim directors of the Division of Cardiovascular Medicine at Vanderbilt University Medical Center.

New Physician Spotlight: Colin Barker

Oct. 14, 2019—Colin Barker, MD, a national leader in percutaneous heart valve therapies, has joined Vanderbilt University Medical Center as the new director of Interventional Cardiology. He began seeing patients July 2.

Heart Institute offering new option to clear carotid arteries

Jul. 24, 2019—Vanderbilt Heart and Vascular Institute is now offering a new procedure that reduces stroke risk for many high-risk patients during interventions for extracranial carotid disease

Device helps heart patients ditch blood thinners

Feb. 7, 2019—For the first time in 27 years, Jerry Flowers is looking at life without using blood thinners, thanks to a small device that was implanted in his heart in a clinical trial at Vanderbilt Heart and Vascular Institute (VHVI).

Bacchetta to help expand pulmonary surgery program

Oct. 25, 2018—Matthew Bacchetta, MD, MBA, MA, has joined the Department of Thoracic Surgery as an associate professor and the surgical director of a new respiratory institute at Vanderbilt University Medical Center that will be launched soon.

VUMC mourns noted cardiologist Crenshaw

Aug. 27, 2018—Marshall H. Crenshaw, MD, assistant professor of Medicine in the Division of Cardiology, died Aug. 23. He was 62.

Novel program gives congenital heart disease patients new options

Aug. 23, 2018—Experts at the Vanderbilt Heart and Vascular Institute are forging new ground in the development of a first-of-its-kind program aimed at adults with congenital heart disease (ACHD).

Multiple options help atrial fibrillation patients

Feb. 22, 2018—Since launching its program offering patients with non-valvular atrial fibrillation (AF) an alternative treatment to reduce their risk of stroke and avoiding long-term use of blood thinners, the Vanderbilt Heart and Vascular Institute (VHVI) has consistently ranked among the top centers in the country for the implantation of left atrial appendage closure (LAAC) devices.